Drospirenone/Estetrol

屈螺酮/雌四醇

Report date: 2026/05/25 20:02:40

Base Information

Drug NameDrospirenone/Estetrol
Drug Alias NameEstetrol+DrospirenoneEstetrol/DrospirenoneDrospirenone+EstetrolDrospirenone and EstetrolEstetrol and Drospirenone +[15] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionProgesterone receptor agonistsEstrogen receptors modulatorsMineralocorticoid receptor antagonists +[4] 
TargetsAndrogen ReceptorEstrogen receptorsMineralocorticoid receptor +[4] 
Therapy Area/IndicationsContraceptionMenstruation Disturbances
Global Approved IndicationsContraceptionMenstruation Disturbances
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2021/04/15
Country/TerritoryBelgiumCanadaUnited States +[9] 
CombinationsYes DrospirenoneEstetrol
Global Highest StatusApproved
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesEstetra S.A.
China Registration ClassN/A

Develop Information

Active CompaniesFuji Pharma Co LtdMayne Pharma Group LtdGedeon Richter Plc
Inactive CompaniesEstetra S.A.
Active IndicationsContraceptionMenstruation Disturbances
Inactive IndicationsN/A

Other Information

ATC CodeG03AA
Related LinksWikipedia